珍寶島(603567.SH):鹽酸氨溴索注射液生產註冊申請獲受理
格隆匯7月7日丨珍寶島(603567.SH)公佈,近日,公司獲得國家藥監局下發的仿製藥鹽酸氨溴索注射液《受理通知書》。
鹽酸氨溴索具有促進粘液排除作用及溶解分泌物的特性,可促進呼吸道內粘稠分泌物的排除及減少粘液的滯留,因而促進排痰,改善呼吸狀況。該項目截至目前累計研發投入約500萬元。
本次生產註冊申請的鹽酸氨溴索注射液,是公司持續對呼吸系統等重大疾病領域進行研發投入的結果。今後公司仍將繼續加大針對重大疾病的化藥、生物藥研發力度。本次生產註冊申請對公司短期的經營業績不構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.